Time To Clinically Meaningful Worsening In Hepatocellular Carcinoma Patients Treated With Lenvatinib or Sorafenib
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.109
https://www.valueinhealthjournal.com/article/S1098-3015(17)30443-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
90
First Page :
A416
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30443-6&doi=10.1016/j.jval.2017.08.109